Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Baker Bros. Decreases Exposure at Viropharma

Julian and Felix Baker‘s hedge fund, Baker Bros. Advisors, now holds around 4.4 million shares of Viropharma Inc (NASDAQ:VPHM), a newly amended filing with the SEC has revealed. Baker Bros. has almost halved its exposure at the company from some 8.3 million shares disclosed in an earlier filing. The new stake amasses 6.7% of Viropharma’s outstanding stock.

Viropharma Inc (NASDAQ:VPHM)

Disclosure: none

Recommended Reading:

Earnest Partners Decreases Position in Astoria Financial Corp; Ups Stake in Meritage Homes Corp

Mario Gabelli, Gamco Buy More Shares of Edgen Group

Palo Alto Investors Sells Out Of Savient Pharmaceuticals